Explore the evolving landscape of state pharmacy regulations in the latest episode of Pharmland. Lawmakers’ stated goals for the more than 1,400 state bills under consideration are to boost transparency in pharmacy benefits, reduce costs, and support independent pharmacies. However, they also have the potential to introduce significant challenges for plan sponsors and patients, including higher pharmacy spend from PBMs passing on incremental costs and a fragmented regulatory environment. Listen in to understand how these state-level changes could impact patient benefits and the complexities facing employers across the country.

Hosts:

Bradley Nelson, PharmD, Vice President, Clinical Services 

Tom Davies, PharmD, Vice President, Clinical Products 

Guest:

Wes Hill, Sr. Director, Managing Counsel, Regulatory & Intellectual Property